Holen Sie sich die Stockscreener-App
0.8622
0.95%
-0.0083
Handel nachbörslich:
.86
-0.0022
-0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.8705
Offen:
$0.917
24-Stunden-Volumen:
158.19K
Relative Volume:
1.68
Marktkapitalisierung:
$48.44M
Einnahmen:
$31.09M
Nettoeinkommen (Verlust:
$-28.51M
KGV:
-1.437
EPS:
-0.6
Netto-Cashflow:
$-22.59M
1W Leistung:
-15.47%
1M Leistung:
-27.55%
6M Leistung:
-2.02%
1J Leistung:
-39.28%
1-Tages-Spanne:
$0.86
$0.92
1-Wochen-Bereich:
$0.86
$1.04
52-Wochen-Spanne:
$0.70
$2.15
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-09-17 | Eingeleitet | Jefferies | Buy |
| 2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
| 2017-08-08 | Bestätigt | Maxim Group | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-05-24 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Bestätigt | MLV & Co | Buy |
| 2015-04-01 | Bestätigt | MLV & Co | Buy |
| 2015-03-05 | Eingeleitet | MLV & Co | Buy |
| 2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Cytosorbents (CTSO) to Release Earnings on Thursday - MarketBeat
Cytosorbents (NASDAQ:CTSO) and Caliber Imaging & Diagnostics (OTCMKTS:LCDX) Critical Comparison - Defense World
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat
Analyst Scoreboard: 5 Ratings For CytoSorbents - Benzinga
Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts - Benzinga
FDA begins review of CytoSorbents' bleeding reduction device - Investing.com
FDA begins review of CytoSorbents' bleeding reduction device By Investing.com - Investing.com UK
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review - StockTitan
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results - StockTitan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 5.7% in September - MarketBeat
CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat
CytoSorbents maintains Buy rating from B.Riley with no change in target price - Investing.com
Cytosorbents announces $20 million "at the market" equity offering - Investing.com
Cytosorbents Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits - Quantisnow
DrugSorb-ATR seeks FDA priority review for surgery bleeding - Investing.com
CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - The Manila Times
Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com - MarketBeat
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - MarketBeat
Stocks of Cytosorbents Corp (CTSO) are poised to climb above their peers - SETE News
Technical analysis of Cytosorbents Corp (CTSO) stock chart patterns - US Post News
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average of $0.94 - MarketBeat
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.com - Defense World
CytoSorbents amends royalty agreement with ROKK LLC - Investing.com
CytoSorbents (STU:HQE1) Earnings Yield % : N/A% (As of Aug. 20, 2024) - GuruFocus.com
B. Riley Analysts Cut Earnings Estimates for Cytosorbents Co. (NASDAQ:CTSO) - MarketBeat
CTSO (CytoSorbents) Inventory-to-Revenue : 0.46 (As of Jun. 2024) - GuruFocus.com
CTSO (CytoSorbents) 3-Year EPS without NRI Growth Rate : -38.10% (As of Jun. 2024) - GuruFocus.com
HC Wainwright Reaffirms “Neutral” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World
Cytosorbents Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
Cytosorbents Co. (NASDAQ:CTSO) Forecasted to Post Q3 2024 Earnings of ($0.05) Per Share - Defense World
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Analysts Offer Predictions for Cytosorbents Co.'s Q1 2025 Earnings (NASDAQ:CTSO) - MarketBeat
Cytosorbents Co. to Post Q1 2025 Earnings of ($0.02) Per Share, HC Wainwright Forecasts (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Announces Earnings Results, Beats Estimates By $0.01 EPS - Defense World
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: CytoSorbents sees growth and prepares for FDA submission - Investing.com
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents names Peter Mariani as new CFO - Investing.com
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results - Quantisnow
Cytosorbents (CTSO) to Release Quarterly Earnings on Tuesday - MarketBeat
Cytosorbents (CTSO) Set to Announce Earnings on Tuesday - Defense World
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results - Yahoo Finance
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):